Kalos Management’s Pfizer PFE Stock Holding History

Kalos Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200	Closed	-$8.16K	–	307
2023 Q1	$8.16K	Buy	+200	New	+$8.64K	0.02%	232
2022 Q3	–	Sell	-6,167	Closed	-$322K	–	92
2022 Q2	$322K	Sell	6,167 -2,685	-30%	-$137K	0.43%	68
2022 Q1	$458K	Sell	8,852 -8,253	-48%	-$428K	0.31%	69
2021 Q4	$813K	Buy	17,105 +657	+4%	+$32.6K	0.22%	108
2021 Q3	$782K	Buy	16,448 +7,435	+82%	+$329K	0.22%	107
2021 Q2	$397K	Sell	9,013 -8,604	-49%	-$335K	0.16%	160
2021 Q1	$685K	Buy	17,617 +8,375	+91%	+$297K	0.21%	113
2020 Q4	$331K	Sell	9,242 -456	-5%	-$16.7K	0.14%	175
2020 Q3	$347K	Buy	9,698 +3,135	+48%	+$110K	0.15%	158
2020 Q2	$223K	Buy	+6,563	New	+$223K	0.09%	183
2015 Q4	–	Hold	0	–	–	–	211

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kalos Management's PFE Position: Q2 2023 in Review

Kalos Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 200 shares — an estimated $8.16K sold.

Kalos Management first reported a position in PFE in Q2 2020 and held it in 10 quarters. The position peaked at $813K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Kalos Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Kalos Management sold 200 Pfizer shares in Q2 2023, an estimated $8.16K.
Kalos Management first reported a position in Pfizer in Q2 2020 and held it in 10 quarters.
Kalos Management's Pfizer position peaked at $813K in Q4 2021.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Kalos Management's 13F filing for Q2 2023, filed 9 Aug 2023.